
Volume 6, Issue 2, Summer 2009
The “Big Three” diseases of Africa are HIV/AIDS, malaria, and TB. To date, we haven’t developed a successful vaccine for any of them, which means that drugs are of enormous importance in controlling the epidemics. For malaria and TB, the spread of drug resistant strains has wreaked public health havoc, restricting our ability to control and eliminate the diseases. (continue reading)
It’s no secret that graduate students spend many hours each day working in the lab, doing the labor of research science. But what exactly are they doing in there? To answer that question, we shadowed Kim Armstrong, a student in the laboratory of Max Essex. (continue reading)
Though he is now an Associate Professor in HIV/AIDS Research at the Nelson Mandela School of Medicine, as well as the Scientific Director of the HIV Pathogenesis Programme at the Doris Duke Medical Research Institute at the University of KwaZulu Natal in South Africa, not so long ago Thumbi Ndung’u was a graduate student working with Max Essex at the Harvard AIDS Initiative. (continue reading)
On April 13th the Harvard AIDS Initiative was honored to host Festus Mogae, the former President of Botswana, who served from 1998-2008. Max Essex, Chair of HAI, introduced President Mogae and outlined his achievements. President Mogae has been a world leader in HIV/AIDS. Nearly a decade ago, when over one-third of the adults in Botswana were HIV-positive, he acknowledged the enormous threat of AIDS to southern Africa and took decisive action...(continue reading)
What do chemical warfare and AIDS research have in common? Both are subjects that Dr. Iain MacLeod, a research fellow in the Essex Lab, has studied extensively. (continue reading)

Download a pdf of the current issue.
| Volume 6 2009 |
Issue 1 |
| Volume5 2007 |
Issue 1 |
| Volume 4 2006 |
Issue 1 |
